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Suc  Succinic acid radical 
Val  Valine radical 
Non  n-Nonyl radical 
CMC  Critical micellar concentration 
MGC  Minimum gelation concentration 
DCC  N,N′-Dicyclohexylcarbodiimide 
DLS  Dynamic light scattering 
NMR  Nuclear Magnetic Resonance  
DMSO_d6 Dimethyl sulfoxide deuterated 
Tgel  Transition temperature of gel to solution 
6  1,6-hexane diamine 
THF  Tetrahydrofuran 
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1.1 Supramolecular gels 
Gels are solid-like viscoelastic materials formed by solvent and gelator. 
Supramolecular gels are formed by weak interactions between small molecules 
unlike macromolecular gels which are formed by macromolecules or polymers.1 
Supramolecular gels can be utilized, for example, in tissue engineering, wound 
healing and drug delivery.2 
 
The dynamic and reversible nature of non-covalent interactions that hold 
supramolecular gels network structures together results in the inherent ability of 
them to respond to external stimuli such as temperature, pH, solvent, light, and 
redox reactions.3 The response to stimuli of supramolecular gels makes them very 
important in Materials Science. For example, some supramolecular gels are 
sensitive to light or chemical entities by incorporating a spectroscopically active 
group or receptor unit as part of a gelator. This makes them easily applicable in 
many areas.4 
 
Supramolecular gels, like other gels, can be classified according to several factors. 
They can be divided into natural and artificial, i.e. synthetic gels, based on a polymer 
acting as a gelling agent. Besides, they can be classified into supramolecular and 
macromolecular based on their structure. Macromolecular gels are those that 
consist of macromolecules and supramolecular those that are built by the self-
assembly of low molecular weight (LMW) molecules.5 The division into physical and 
chemical gels is based on their bridging mechanism. Physical gels are made up of 
non-covalent interactions and chemical gels are made up of covalent bonds.6,7 Also, 





Figure 1.1 Formation of supramolecular gels.8 
 
1.2 Hydrogels 
Hydrogels are soft materials formed from hydrophilic polymeric networks that can 
swell in the presence of water or physiological fluids (Figure 1.2). 9,10 Hydrogels can 
absorb or bind considerable amounts of water relative to their dry weight.9,8,12As 
mentioned above, chemical hydrogels are formed by covalent networks and do not 
dissolve in water without breaking covalent bonds. However, physical hydrogels are 
formed through dynamic interactions of synthetic or natural building blocks based 
on non-covalent interactions, such as hydrophobic and electrostatic interactions or 
hydrogen bonding.11  
The nature of the water in the hydrogel can determine the ability of solutes to 
penetrate the gel and cell products. As the dry hydrogels begin to absorb water, the 
first water molecules entering the matrix hydrate the most polar, hydrophilic 
groups, resulting in "primary bound water." As the polar groups hydrate, the 
network swells and exposes the hydrophilic groups to interactions with water 
molecules, resulting in hydrophobically bound water or "secondary bound water." 
Once the polar and hydrophobic sites have interacted and attached to the water 
molecules, excess water is absorbed into the network due to the osmotic pressure 
of the network chains. Covalent or physical bridge bonds resist this additional 
swelling, resulting in an elastic retraction force of the network. Thus, the hydrogel 
reaches equilibrium in its swelling level.9 
Hydrogels have been increasingly studied in the field of tissue engineering. 
Hydrogels designed for use in tissue engineering building platforms may contain 
pores large enough to accommodate living cells. They can be designed to dissolve 
or disintegrate, release growth factors, and create pores into which living cells can 
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penetrate and multiply. However, a significant disadvantage of hydrogels is their 
low mechanical strength, which causes significant difficulties in their handling. Also, 
sterilization of hydrogels is very challenging.12 
Supramolecular hydrogels are probably the most promising soft material substrates 
in modern biomedical applications. With their inherent reversibility and dynamism, 
they respond well to environmental stimuli and biochemical cues and can 
decompose mechanical energy efficiently. These essential features are well suited 
for cell culture, tissue engineering, controlled release of therapeutic agents as 
needed (Figure 1.3), tissue adhesion, and molecular recognition. They can also be 
used as artificial gel substitutes in organs that are not readily achieved by 
permanently crosslinked covalent hydrogels. Supramolecular interactions that 
allow gel formation also translate into the properties of their bulk materials and 
lead to biomedical applications. Because of the diversity and ease of "bottom-up" 
design, at the molecular level, supramolecular hydrogels offer a wide range of 
biomedical solutions to modern societal problems, including wound healing, 
artificial tissue development, cell therapies, and cancer treatment.13, 14 
 
 
Figure 1.2 Creation of polymeric hydrogels by crosslinking (left) or formation of 






Figure 1.3 Representation of a temperature-triggered drug release system.1 
1.3 Organogels 
Supramolecular organogels are semi-solid materials consisting of a gelator and an 
organic solvent. Supramolecular organogels have numerous applications. They can 
serve, for example, as molds for the production of nanoporous materials or 
nanoparticles, as media for the growth of large, high-quality organic, inorganic and 
macromolecular crystals, and as electro-optical display materials.15 
Organogels can be classified into polymeric and supramolecular organogels based 
on the nature of the gelling molecule. In supramolecular organogels, gel networks 
are networks formed of either solid or liquid fibers. Liquid fibers gel organic solvents 
in the same way as solid fibers: the size of the aggregate increases, and the 
adhesion of the formed structures immobilizes the solvent as a result of surface 
tension. Solid and liquid fiber networks behave differently from each other. The 
morphology of solid network structures is permanent throughout the life cycle of 
the gel, but fluid networks are temporary structures that re-form dynamically 
throughout time. For example, lecithin and sorbitan monostearate are both of great 
interest in pharmaceutical applications because they are composed of liquid fiber 
networks.16 
Supramolecular organogels are used for topically or transdermally administered 
drugs. This approach to drug distribution represents a noninvasive method with 
good tolerance. Pharmaceutical supramolecular organogels are generally formed 
in biocompatible oils or alcohols, such as n-butanol, n-octanol, ethyl oleate, 
glycerin, or eucalyptus oil. These substances are usually permeation enhancers that 
facilitate the passage of drugs through the epidermis.1 
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1.4 Surfactant type gels 
Surfactants are molecules consisting of a water-repellent or hydrophobic and 
hydrophilic moiety. Indeed, in the production of surfactants, it is essential to 
combine these two different types of groups.15–18 The hydrophobic moiety is a 
hydrocarbon chain of 5–18 carbon atoms with low polarizability. The hydrophilic 
moiety, in turn, may be nonionic, ionic or zwitterionic. The balance between these 
two different parts gives the surfactants their specific properties, such as 
accumulation at various interfaces and association in solution.17 
 
Surfactants are found in almost every chemical product, such as detergents, paints, 
dyes, paper coatings, inks, plastics and fibers, personal care products and 
cosmetics, agrochemicals, pharmaceuticals, and food. Besides, they play an 
essential role in the oil industry.16–18 The most common surfactants are soaps, i.e., 
fatty acid salts containing a chain of at least eight carbon atoms, and detergents, 
which can be mixtures of several different surfactants. Detergents alter the 
properties of the interfaces to promote the removal of phase, such as dirt, from 
solid surfaces.22 
 
Amphiphilic mixtures can, in some cases, be gel phases at a specific concentration 
and temperature range. For example, <70% potassium stearate in water forms clear 
gels below 50 °C. The area per polar main group is equal to twice the cross-sectional 
area per paraffin chain. The relationship between these two regions suggests that 
the soap molecules pack in an interdigitated arrangement within the layers. The 
formation of hydrogel phases from other alkali metal alkanoates depends on the 
nature of both the cation and the alkanoate anion species. Different chain lengths 
for alkanoate anions can lead to different gelator efficiencies. For hydrogels of 
alkanoate anions having a chain length of 14 to 22 carbon atoms and having the 
same cation, the disassembly temperature values increase with increasing chain 
length. Specific concentrations of potassium, rubidium, and cesium salts of 
alkanoates of the same chain length also produce gel phases in water, whereas 





1.5 Techniques for the characterization of supramolecular gels 
A variety of skills and techniques must be used to understand gelation (Figure 1.4). 
For example, nuclear magnetic resonance (NMR) spectroscopy, infrared 
spectroscopy, circular dichroism, fluorescence, and X-ray diffraction are used to 
understand molecular packing. While all of these techniques can be informative, 
they are always accompanied by remarks. For example, circular dichroism is very 
sensitive to concentrations, and good quality data can often only be collected at 
concentration values lower than the minimum gelation concentration (mgc). 
Therefore, it is questionable whether the packing of aggregates below mcg is the 
same as that of mgc and above. Likewise, fluorescence cannot be easily collected 
in turbid samples, and higher concentrations make it difficult to obtain due to 
quenching. Additionally, X-ray diffraction assumes that the diffraction is from the 
gel phase and not from crystalline impurities. Nevertheless, such techniques can be 
very informative. For example, NMR spectroscopy can be used to test velocity and 
infer information about molecular interactions leading to assembly. Similarly, 
infrared spectroscopy can be used to show that a particular hydrogen bond occurs 
in the assembly.8 
 
Figure 1.4 As a result of assembly, low molecular weight gels form structures on 




1.6 N-protection and C-activation in peptide synthesis 
Peptide synthesis has become one of the most reliable and predictable fields of 
practical organic chemistry, mainly because of the effectiveness of the protecting 
groups it uses. Biology makes peptides and proteins by selectively linking members 
of a pool of about 20 amino acids. To do the same in the laboratory, we must 
overcome several challenges. For example, by reacting two amino acids together, 
one could make a dipeptide such as leucine and glycine (Figure 1.5). For the NH2 
group of glycine to react with the CO2H group of leucine, the carboxylic acid must 
first be activated towards nucleophilic substitution. For example, by making an acyl 
chloride or a particularly reactive ester, designated RCOX. The biggest problem is 
that there is another free CO2H that can react with the COX group to form an 
anhydride, and two different free amines, each of which can react. For this reason, 
both the NH2 group of leucine and the CO2H group of glycine should be protected. 
The protecting groups must be removable under mild conditions, but two groups 
(one for each of NH2 and CO2H) are also required, which can be removed under 
different conditions. It is then possible to modify both ends of the dipeptide if 
desired 22 
 
Figure 1.5 Schematic representation of the synthesis of a dipeptide.22 
Molecules that are prepared in this work require methodology commonly used in 
peptide synthesis. Cbz (benzyloxycarbonyl), Boc (t-butyloxycarbonyl) and Fmoc (9-
fluorenylmethoxycarbonyl) groups are widely used to protect the amino group. On 
the other hand, activation of the carboxyl group for peptide bond formation is 






































Molecule SucValNon (Scheme 2.1) had been studied previously as a low molecular 
weight hydrogelator in the research group where this work has been carried out. 
Studies by the group have shown spherical particles of the gel corresponding to the 
early stages of aggregation into fibers.23 SucValNon, and related molecules, form 
gels in water in its neutral form. However, accidentally it was found that its ionic 
form, carboxylate, present at basic pH values, tended to form also hydrogels. This 
fact is, a priori, unexpected due to the improved solubility in water of the ionic form 
compared to the neutral one. With this consideration mind, the following 
objectives were established. 
1) Reproduce the synthesis and characterization of SucValNon, using 
conventional organic synthesis procedures. 
2) Synthesize an analogue SucVal6, dicarboxylic acid, related to SucValNon 
3) Evaluate the capability of gel formation by the carboxylate form of 
SucValNon. 
4) Evaluate the capability of gel formation by the carboxylate form of SucVal6. 
This point was not developed because of the stop of academic activity 
associated with the Covid19 pandemics. 
 
 
Figure 2.1 Molecular structure of SucValNon. 
 
 























































Results and Discussion 
 
3.1 Synthesis of SucValNon 
 
Scheme 3.1 Reagents and conditions: a) DCC, N-hydroxisuccinimide, THF, 0 °C, 1 h, 
84 %; b) n-nonylamine, THF, overnight, 50 °C, 77 %; c) ) Pd/C, H2, MeOH, 2 h, 85 %; 
d) Succinic anhydride, K2CO3, THF, overnight, 70 %. 
 
Scheme 3.1 shows the general process of synthesis of SucValNon. The preparation 
is divided into four main steps. The first step was the activation of Carbobenzyloxy-
L-valine as an activated ester using N,N'-Dicyclohexylcarbodiimide and N-
hydroxisuccinimide (Scheme 3.2). The second step was an aminolysis coupling of 
the activated ester and n-nonylamine, forming an amide bond (Scheme 3.3). The 
third step was the removal of the Cbz protecting group by hydrogenolysis using 
Pd/C as a catalyst (Scheme 3.4). Finally,  SucValNon was obtained by reaction 
between the amine and succinic anhydride. 
 
 





Scheme 3.3 Peptide bond formation. 
 
 
Scheme 3.4 Hydrogenolysis reaction for removal of the protecting group Cbz. 
 
3.2 Synthesis of SucVal6 
 
Scheme 3.5 Reagents and conditions: a) 1,6-Hexanediamine, THF, N2, 50 °C, 
overnight, 99%; b) Pd/C, H2, MeOH, 3 h, 71%; c) Succinic anhydride, K2CO3, THF, 
overnight, 37%. 
Scheme 3.5 shows the synthesis of SucVal6. The stages in the synthesis of SucVal6 
are the same as in the synthesis of SucValNon. The only difference is that n-
nonylamine was used instead of 1,6-Hexanediamine. 
 
3.3 Minimum gelation concentration 
Minimum gelation concentration (MGC) describes the lowest possible 




value for the ionic form of SucValNon was studied in the presence of Na+ and K+ 
cations. SucValNon was dissolved in basic aqueous medium using alkaline (Na or K) 
hydroxides with a final pH of ca. 12, which assures the formation of the anionic 
carboxylate species. The amount of alkaline cation was regulated by the addition of 
the corresponding chlorides, affording systems with a final alkaline cation 
concentration of 0.1 M, 0.5 M and 1.0 M. The maximum concentration of 
SucValNon tested was 20 mg/mL. It can be observed that with a 0.1 M 
concentration of the alkaline cation, no gel was formed. Upon increasing to 0.5M, 
a gel was formed only in the presence of sodium. Finally, for a concentration of 1 
M, both systems, containing sodium and potassium cations, developed a gel. The 
results show that gel formation is sensitive to alkaline cation's nature and 
concentration. The bigger the ionic strength, the better is the gelation capability. 
Additionally, it seems that sodium favors gel formation to a higher degree than 
potassium cation. Figures 3.1 and 3.2 show pictures of the samples used in the 
experiments carried out to assess the gelation capabilities. 
Table 3.1. Minimum gelation concentration of SucValNon in water, pH > 12, in the 
presence of sodium and potassium cations. 
M+ [M+] / M MGC / mg mL-1 
Na+ 0.1 No gel 
Na+ 0.5 20 + 1 
Na+ 1 20 + 1 
K+ 0.1 No gel 
K+ 0.5 No gel 
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Figure 3.1 Pictures of vial inversion tests for SucValNon in Na+ solutions. 
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 SucValNon and SucVal6 were successfully prepared in gram scale in pure 
form. 
 
 The MGC for SucValNon in 0,5 M [Na+] solution and in 1,0 M [K+] solution 
is 20 mg mL-1 
 
 Hydrogel formation is dependant on the concentration and nature of the 




































 Experimental Section 
 
5.1 General methods 
1H/13C NMR spectra were recorded on a Varian Unity of 500 MHz and 400 MHz in 
the indicated solvent at 30 ºC. Signals of the deuterated solvent (DMSOd6 or CDCl3) 
were taken as the reference in DMSO-d6, the singlet at 2.50 and the quadruplet 
centered at 39.52 ppm for 1H and 13C NMR, respectively, and the reference in CDCl3, 
the singlet at 7.26  and singlet at 77.16  ppm for 1H and 13C NMR. 1H and 13C signals 
were assigned with the aid of 2D methods (COSY, HSQC and HMBC). Reactions 
which required an inert atmosphere were carried out under N2. Commercially 
available reagents were used as received. In the characterization of the spectra the 
abbreviations s, d, t, q, p, m, br, dd which means singlet, doublet, triplet, 
quadruplet, quintet, multiplet, broad and doublet of doublets. 
Mass spectra were run by the electro-spray mode (ESMS). Masses spectra were 
recorded at Mass Spectrometry triple Quadrupole Q-TOF Premier (Waters) with 
simultaneous Electrospray and APCI Probe. 
 
5.2 Synthesis of SucValNon 
 
Scheme 5.1 Reagents and conditions: a) DCC, N-hydroxisuccinimide, THF, 0 °C, 1 h, 
84 %; b) n-nonylamine, THF, overnight, 50 °C, 77 %; c) ) Pd/C, H2, MeOH, 2 h, 85 %; 






5.2.1 Synthesis of ZValOSu 
 
Scheme 5.2 Synthesis of ZValOSu 
A solution of commercial available carbobenzyloxy-L-Valine and N-
hydroxysuccinimide (1.0 eq.) in dry THF (150 mL) was added dropwise under N2 at 
0 ºC with a dropping funnel to a solution of N,N′-dicyclohexylcarbodiimide (1.01 
eq.) in dry THF (75 mL). The mixture was further stirred for 1 h at 0 ºC. The solution 
was then allowed to stand into refrigerator for 2 h, which caused precipitation of 
N,N′-dicyclohexylurea. After this time, the mixture was filtered under vacuum, and 
the filtrate was removed under reduced pressure and the crude residue was 
purified by crystallization in isopropanol to yield the respective activated ester. 
2,5-dioxopyrrolidin-1-yl ((benzyloxy)carbonyl)-L-valinate (ZValOSul): A white solid 
was obtained (11,69 g, yield 84%); the NMR spectra were consistent with those 
described in the literature.1 
1H NMR (DMSO-d6): δ 8.04 (s, 2H), 7.36 (t, 4H), 7.30 (s, 1H), 5.09 (t, 4H), 4.35 (m, 
1H), 2.72 (d, 6H), 2.27–2.11 (), 1.09 – 0.93 (m, 6H). 
  
5.2.2 Synthesis of ZValNon  
 
Scheme 5.3 Synthesis of ZValNon 
 
A solution of carbobenzyloxy-L-amino ester activated (ZValOSu, 1.0 eq.mmol) in 
THF (25 mL) was added dropwise under N2 at room temperature with a dropping 
                                                                
1 J., Becerril; M., Bolte; M., I., Burguete; F., Galindo; E., García-España; S., V., Luis; J., F., Miravet. 




funnel to a solution of commercial available n-nonylamine (1.1 eq.) in THF (15 mL). 
The mixture wasfurther stirred for 5 h at 55 ºC. After this time, the mix was cooled 
to room temperature and solvent was removed under reduced pressure and the 
residue was poured into dissolution aq. HCl 0.1 M, then the mix was sonicated 
during 5 minutes. It was filtered under vacuum, and the residue was washed with 
water until pH = 7. The residue was dried under reduced pressure at 50ºC overnight. 
Benzyl (S)-(3-methyl-1-(nonylamino)-1-oxobutan-2-yl)carbamate (ZValNon): A 
white solid was obtained (1,53 g, yield 77%). 
1H NMR (DMSO–d6): δ 7.86 (t, J = 3 Hz, 1H), 7.41–7.27 (br s, 5H), 7.19 (d, J = 9 Hz, 
1H), 5.03 (s, 2H), 3.79 (t, J = 9 Hz, 1H), 3.16–2.93 (m, 2H), 1.93 (m, 1H), 1.37 (s, 2H), 
1.29 (m, 2H), 1.24 (s, 12H), 0.86 (d, J = 6 Hz, 9H). 
13C NMR (DMSO-d6): δ 170.8, 156.0 (C=O), 137.1, 128.2, 127.7, 127.5 (CH), 65.3 
(CH2), 60.3 (CH), 38.3 (CH2), 31.2 (CH), 30.2, 28.9, 28.9, 28.7, 28.6, 26.3, 25.2, 22.0 
(CH2), 19.1, 18.2, 13.9 (CH3). 
 
5.2.3 Synthesis of HValNon 
 
Scheme 5.4 Synthesis of HValNon 
 
Palladium catalyst (20% w/w) was suspended in MeOH (30 mL) and stirred under 
H2 at room temperature for 10 min. Subsequently, a solution of ZValNon (500 mg) 
in MeOH (10 mL) was added via syringe, followed by stirring under H2 at room 
temperature for 2 h. The reaction mixture was then filtered through Celite®, and 
the solvent was removed under reduced pressure to yield respective amine. 
(S)-2-amino-3-methyl-N-nonylbutanamide (HValNon): White solid was obtained 
(250 mg, yield 85%). The compound was used in crude form for the next reaction. 
1H NMR (DMSO – d6): δ 7.75 (t, J = 3.5 Hz, 1H), 3.14–2.93 (m, 2H), 2.88 (d, J = 5 Hz, 




13C NMR (DMSO-d6): δ 174.2 (C=O), 60.0 (CH), 39.6 (CH2), 31.6 (CH), 31.2, 29.2, 29.0, 
28.6, 26.3, 22.1 (CH2), 19.4, 17.1, 13.9 (CH3). 
 
5.2.4 Synthesis of the final compound SucValNon 
 
Scheme 5.5 Synthesis of SucValNon 
 
A solution of respective HValNon (1 eq.) in THF (50 mL) was treated at 0 ºC under 
N2 with solid K2CO3 (3.8 eq.). The mixture was stirred for 15 minutes at 0 ºC, after 
with a dropping funnel to a solution of commercial available succinic anhydride (2.0 
eq.) in THF (20 mL). The mixture was further stirred vigorously for 16 h at room 
temperature. After this time, the solution was concentrated under reduced 
pressure and the crude residue was dissolved in water (100 mL); then hydrochloric 
acid concentrate was added dropwise at 0 ºC until observe the formation of a white 
precipitate to pH = 4. The white solid obtained was filtered under vacuum, and the 
residue was washed with water (300 mL). The compound was dried under reduced 
pressure at 50 ºC overnight. 
(S)-4-((3-methyl-1-(nonylamino)-1-oxobutan-2-yl)amino)-4-oxobutanoic acid 
(SucValNon): A white solid was obtained (304 mg, yield 70%) as a white solid. 
1H NMR (DMSO–d6): δ 12.06 (s, 1H), 7.83 (t, J = 10 Hz, 1H), 4.07 (t, J = 10 Hz, 1H), 
3.18–2.87 (m, 1H), 2.44–2.36 (m, 2H), 1.93 (m, 1H), 1.47–1.35 (m, 1H), 1.23–1.14 
(s, 12H), 0.88 (t, J = 5 Hz, 3H), 0.81 (d, J = 5 Hz, 6H). 
13C NMR (DMSO-d6): δ 174.3 (COOH), 171.4, 171.2 (C=O), 58.3 (CH), 41.8, 40.4, 
40.1, 40.0, 39.9, 39.6, 39.3, 38.7, 31.7, 30.9, 30.4, 29.8, 29.2, 26.8, 22.5 (CH2), 19.6, 







5.3 Synthesis of SucVal6 
 
Scheme 5.6 Reagents and conditions: a) 1,6-Hexanediamine, THF, N2, 50 °C, 
overnight, 99%; b) Pd/C, H2, MeOH, 3 h, 71%; c) Succinic anhydride, K2CO3, THF, 
overnight, 37%. 
 
5.3.1 Synthesis of ZVal6 
 
Scheme 5.7 Synthesis of ZVal6 
 
ZVal6, was obtained following the same procedure for the synthesis of ZValNon , 
except that two equivalents of ZValOSu was used by one equivalent of 1,6-diamine 
hexane.  
Benzyl ((5R,16S)-5-isopropyl-17-methyl-3,6,15-trioxo-1-phenyl-2-oxa-4,7,14-
triazaoctadecan-16-yl)carbamate (ZVal6): A white solid was obtained (4,10 g, yield 
99%) as a white solid. 
1H NMR (DMSO–d6): δ 7.86 (t, J = 5.3 Hz, 1H), 7.42 -7.20 (m, 5H), 7.18 (d, J = 8.9 Hz, 
1H), 5.02 (s, 2H), 3.86 – 3.69 (m, 1H), 3.03 (ddd, J = 19.3, 13.4, 6.7 Hz, 2H), 1.90 (dt, 
J = 13.4, 6.7 Hz, 1H), 1.41 – 1.35 (m, 2H), 1.34 – 1.23 (m, 2H), 0.83 (d, J = 6.7 Hz, 6H). 
13C NMR (DMSO-d6): δ 170.9, 156.1 (C=O), 137.1 (C), 128.3, 127.7, 127.6(CH), 65.3 




5.3.2 Synthesis of HVal6 
 
Scheme 5.8 Synthesis of HVal6 
 
HVal6, was obtained following the same procedure for the synthesis of HValNon.  
(S)-2-amino-N-(6-((R)-2-amino-3-methylbutanamido)hexyl)-3-methylbutanamide 
(HVal6): A white solid was obtained (2,35 g, yield 71%) as a white solid. The 
compound was used in crude form for the next reaction. 
1H NMR (DMSO–d6): δ 7.76 (t, J = 5.4 Hz, 1H), , 3.04 – 2.90 (m, 2H), 2.88 (d, J = 5.3 
Hz, 1H),  1.96 – 1.80 (m, 1H), 1.55 – 1.21 (m, 2H), 1.21 – 1.12 (m, 2H), 0.85 (d, J = 
6.8 Hz, 3H), 0.77 (d, J = 6.8 Hz, 6H). The amines signals (-NH2) were very broads and 
cannot distinguish in the spectrum. 
13C NMR (DMSO-d6): δ 174.4 (CO), 48.6 (CH), 38.1, 31.6, 29.2, 26.1 (CH2), 19.5, 17.1 
(CH3). 
 
5.3.3 Synthesis of the final compound SucVal6 
 
Scheme 5.9 Synthesis of SucVal6 
 
SucVal6, was obtained following the same procedure for the synthesis of 
SucValNon , except that double of equivalents of succinic anhidre and K2CO3 was 
used by one equivalent of HVal6. 
(6R,17S)-6,17-diisopropyl-4,7,16,19-tetraoxo-5,8,15,18-tetraazadocosanedioic 





1H NMR (DMSO_d6): δ 12.04 (s, 1H), 7.91 – 7.83 (m, 2H), 4.07 (dd, J = 8.6, 7.1 Hz, 
1H), 3.01 (dtt, J = 25.7, 12.8, 6.6 Hz, 2H), 2.47 – 2.27 (m, 4H), 1.92 (dq, J = 13.5, 6.7 
Hz, 1H), 1.37 (dd, J = 13.8, 6.7 Hz, 1H), 1.19 (dt, J = 17.1, 5.8 Hz, 1H), 0.81 (d, J = 6.6 
Hz, 3H). 
13C NMR (DMSO-d6): δ 174.4, 171.5, 171.2 (C=O), 58.3 (CH), 38.8, 30.9, 30.4, 29.7, 
29.1, 24.2 (CH2), 19.67, 18.59 (CH3). 
 
 
5.4 Experimental method for determination of MGC 
A stock dissolution of MOH 0.1 M (M= Li, Na or K) was prepared; the concentration 
of cation (M+) was adjusted by the addition of solid MCl.  
In a typical experiment, 20 mg of SucValDoc and 1 mL of stock dissolution were 
introduced into a cylindrical screw-capped glass vial (8 mL, diameter =1.5 cm). The 
system was heated up with heat air to 100ºC with a heat gun. Once the solid was 
dissolved, the system was cooled by immersion into a water bath at 25ºC for 30 
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